Corey Davis, J.D., M.S.P.H., serves as Director of the Network’s Harm Reduction Legal Project. Corey was previously a Senior Attorney at the National Health Law Program (NHeLP), where he helped to advance access to quality health care for low-income and underserved individuals. Before joining NHeLP Corey served as Employment Rights Attorney at Equality Advocates Pennsylvania, where he represented lesbian, gay, bisexual and transgender (LGBT) individuals before administrative commissions and in state and federal courts. He previously oversaw a street-based legal clinic sited at Philadelphia’s syringe exchange program.
Corey has served as chair of a county board of health, chair of the board of the North Carolina Harm Reduction Coalition, and vice-chair of the North Carolina Harm Public Health Foundation, among other positions. He is a recipient of the International AIDS Society’s Young Investigator Award andhas published extensively in the lay and academic press. Corey received his B.S. from the Indiana University of Pennsylvania, his M.S.P.H. from the University of North Carolina at Chapel Hill and his J.D. from Temple University. Corey is barred in Pennsylvania and New Jersey as well as various federal courts.
View a collection of research, resources and trainings produced by Corey below.
This fact sheet briefly discusses the efficacy of expired naloxone and examines whether South Carolina law permits the distribution and administration of such naloxone.
This fact sheet briefly discusses the efficacy of expired naloxone and examines whether North Carolina law permits the distribution and administration of such naloxone.
This fact sheet briefly discusses the efficacy of expired naloxone and examines whether Oregon law permits the distribution and administration of such naloxone.
by Overview 1:00 – 2:30 p.m. ET | December 15, 2021Attend this webinar for an examination of some of the most important and…
This fact sheet briefly discusses the efficacy of expired naloxone and examines whether Washington law permits the distribution and administration of such naloxone.
This fact sheet briefly discusses the efficacy of expired naloxone and examines whether California law permits the distribution and administration of such naloxone.
The United States remains in the grip of both COVID-19 and drug-related harm. Both are public health emergencies marked by tens of thousands of preventable deaths – and both disproportionately impact Black, Hispanic, Native, and other non-White people. Addressing the structural racism that drive inequality in access to economic opportunity, educational attainment, and other factors that ultimately drives health disparities must be a key public health priority – both during the dual COVID and overdose epidemics and beyond.
The medications for opioid use disorder, methadone and buprenorphine, can reduce overdose deaths by over 50 percent. Unfortunately, many people who want to access these medications are unable to do so because of federal and state legal restrictions, primarily the federal X-waiver, which a physician must obtain in order to prescribe these medications. While the requirement itself is statutory and can only be changed by Congress, the departments of Justice and Health and Human Services (HHS) have a great deal of autonomy in determining its exact contours.
We conducted a systematic legal review to determine the prevalence and characteristics of state laws that require some or all hospital emergency departments to create protocols to screen patients for substance use disorder as well as those that require that hospitals take specific actions when providing care to such individuals or individuals who have experienced an overdose.
Over the past ten years, there have been important and lifesaving efforts to address drug related harm. All states have passed laws increasing access to the overdose reversal medication naloxone and nearly all have passed overdose Good Samaritan laws, and dedicated advocates have succeeded in legalizing syringe services programs in several states. Unfortunately, law still overwhelmingly works to increase, rather than decrease, risks to people who use drugs. In this commentary, Corey Davis, director of the Network’s Harm Reduction Legal Project, reflects on efforts to address the opioid epidemic and why additional systemic change is needed. Read more.
This resource summarizes the characteristics of naloxone access and Good Samaritan laws in 50 states and the District of Columbia.
In this webinar, presenters will describe the nature of the laws being announced from the judicial bench or proposed in state legislatures, the process by which they are being formulated in every level and branch of government, and the principles that should guide legal developments as we seek to balance the facts, expert opinion, and civic participation, as well as guard against harmful unforeseen consequences.
